Recruitment of immune-suppressive cells in poor responders
non-IE
To investigate TME dynamics during neoadjuvant PD-L1 blockade, we evaluated the changes in TME phenotype, chemokines and tumor-infiltrating immune cells. In total, 50% (3/6) of the IE subtype showed an overall anti-tumor response trend toward the non-IE subtype after nAde (Fig. 